Page last updated: 2024-10-21

phenytoin and Cruveilhier-Baumgarten Syndrome

phenytoin has been researched along with Cruveilhier-Baumgarten Syndrome in 1 studies

Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.

Research Excerpts

ExcerptRelevanceReference
"Phenytoin is an antiepileptic drug that is primarily eliminated by hepatic metabolism."1.62Phenytoin Toxicity After Transjugular Intrahepatic Portosystemic Shunt (TIPS). ( Aminlari, A; Bassell, T; Del Rosso, J; Hayden, S; Ly, BT, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bassell, T1
Aminlari, A1
Hayden, S1
Del Rosso, J1
Ly, BT1

Other Studies

1 other study available for phenytoin and Cruveilhier-Baumgarten Syndrome

ArticleYear
Phenytoin Toxicity After Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    The Journal of emergency medicine, 2021, Volume: 60, Issue:1

    Topics: Humans; Hypertension, Portal; Phenytoin; Portasystemic Shunt, Transjugular Intrahepatic; United Stat

2021